Yokoi K, Tanei T, Godin B, van de Ven AL, Hanibuchi M, Matsunoki A, Alexander J, Ferrari M. Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments. Cancer Lett. 2014 Apr 1;345(1):48-55.

Yokoi K, Kojic M, Milosevic M, Tanei T, Ferrari M, Ziemys A. Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment. Cancer Res.2014 Aug 15;74(16):4239-46.

Yokoi K, Chan D, Kojic M, Milosevic M, Engler D, Matsunami R, Tanei T, Saito Y, Ferrari M, Ziemys A. Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier. J Control Release. 2015 Sep 23. pii: S0168-3659(15)30144-9.

Tomonori Tanei, Fransisca Leonard, Xuewu Liu, Jenolyn F. Alexander, Yuki Saito, Mauro Ferrari, Biana Godin, Kenji Yokoi. Redirecting transport of nanoparticle albumin-bound paclitaxel to macrophages enhances therapeutic efficacy against liver metastases. Cancer Res. 2016 Jan 15;76(2):429-39.

Ziemys A, Yokoi K (co-first author), Kai M, Liu YT, Kojic M, Simic V, Milosevic M, Holder A, Ferrari M. Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance. J Control Release. 2018 Dec 10;291:99-105.

Kai M, Ziemys A, Liu YT, Kojic M, Ferrari M, Yokoi K. Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy. Transl Oncol. 2019 Sep;12(9):1196-1205.

View All Publications